Istaroxime has completed four positive Phase 2 studies, including two in early cardiogenic shock (called SCAI Stage B). Market research conducted by the Company with U.S. based clinical cardiologists ...

Can-Fite looks forward to engaging with potential partners and collaborators at BIO 2025 as it continues to progress its clinical pipeline. About Can-Fite BioPharma Ltd.

The products contain a drug called tianeptine, which is addictive and has not been FDA approved. 'Nation of immigrants and a nation of laws': Obama speaks out about immigration ...

Dr. Lbiati’s appointment signals a new chapter for Hepion—one focused on strategic renewal, value creation, and diagnostic innovation in areas of significant unmet clinical need, including celiac ...